基本信息
views: 7
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr Edouard Fu is a postdoctoral fellow in cardiometabolic/renal pharmacoepidemiology at BWH & Harvard, and editor at NDT. He received his PhD in 2021 cum laude, given to top dissertations in the field, for the thesis “Optimal cardiovascular treatment strategies in kidney disease - causal inference from observational data”. His PhD was fully funded by an MD/PhD grant (150k Euros) from the Board of Directors of Leiden University Medical Center. Prior to this, he completed both his bachelor’s degree in Medicine and Honors degree in clinical research cum laude (2018), and was editorial fellow at the leading kidney journal JASN (2021-2023). He is also an epidemiologist with training in causal inference and clinical epidemiology.
His research focuses on assessing the effectiveness and safety of medications and treatments in patients with kidney and cardiovascular disease by applying state-of-the art causal inference methods to routinely collected healthcare data. He has investigated the cardiorenal effects of ACEi/ARB, MRA, β-blockers, SGLT2i, DOACs and GLP1-RA, as well as the effectiveness and timing of dialysis initiation. He pioneered the application of target trial emulation in the field of nephrology to answer clinically pressing questions with observational data (e.g. BMJ 2021, JASN 2020), which has improved the validity of causal observational studies. He is currently involved in several large ongoing pharmacoepidemiologic analyses and has published over 90 peer-reviewed articles and conference proceedings in general medical journals (BMJ, Annals of Internal Medicine) and specialty journals in the field of nephrology (JASN, Kidney Int) and cardiology (European Heart Journal, European Journal of Heart Failure). In addition, he has written several educational articles to make advanced methods more accessible for clinicians (NDT, CKJ, JASN).
His work has been awarded with various prizes, including best abstract by a young author (2019) and best abstract of the congress (2021) at the ERA conferences. Furthermore, he received the prize for best Dutch PhD thesis in nephrology, and prize for best paper from the Dutch Epidemiology Society (2022). He recently received a prestigious Rubicon grant from the Dutch Research Council and a Junior Kolff Grant (€374.000). He was chosen as one of the 30 talents under 30 of The Netherlands by Elsevier (2022) and received the Stanley Shaldon Award from the European Renal Association for his scientific contributions to nephrology (2023).
Research Interests
Papers共 99 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
BMJ (Clinical research ed.) (2024): e078483-e078483
Diabetes Research and Clinical Practice (2024): 111745-111745
KIDNEY INTERNATIONALno. 3 (2024): 618-628
Nephrology Dialysis Transplantationno. Supplement_1 (2024)
Nephrology Dialysis Transplantationno. Supplement_1 (2024)
Nephrology Dialysis Transplantationno. Supplement_1 (2024)
Nephrology Dialysis Transplantationno. Supplement_1 (2024)
AMERICAN JOURNAL OF KIDNEY DISEASESno. 3 (2024): 293-305.e1
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Associationno. 4 (2024): 694-706
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn